Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Discover practical ways to cope when financial surprises arise. Learn to adjust spending, build a small buffer, and prioritize essential expenses.
18,243 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
A new survey shows most retirement mistakes show up after retirement, as market swings and withdrawal strategies thre...
As Bausch Health prepares its Q4 2025 results, investors want clarity on margins, debt, and the pipeline. This guide ...
If you’re building a portfolio meant to last, choosing the right coffee stock matters. This guide compares Dutch Bros...
Two big catalysts could push XP stock higher: regulatory clarity in Brazil’s fintech scene and stronger cross-selling...
Honeywell slashed the price of a $1.92 billion chemicals acquisition by $500 million, a 26% concession tied to softer...
A high-net-worth retiree explains why testing retirement before quitting matters and outlines a disciplined, income-f...
Nova Measuring Instruments rode an 80% gain in the past year, but a big insider sale prompts question. This guide bre...
MercadoLibre posted a solid Q4 revenue beat alongside an earnings miss, underscoring margin pressure from growth init...
A major partnership reshapes Novo Nordisk's growth trajectory. This deep dive explains what the Vivtex deal means for...
Scorpio Tankers has moved from a debt-laden balance sheet to net cash of roughly $334 million by early 2026, a develo...
A high-stakes clash between Anthropic and the Pentagon nears a Friday deadline, drawing attention from markets and pe...